Loading stock data…
RMTI
$0.89+0.01 (+1.29%)
Market ClosedLast close May 1
Rockwell Medical, Inc., together with its subsidiaries, develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Rockwell Medical, Inc. in the Healthcare sector is trading at $0.89. The stock is currently near its 52-week low of $0.78, remaining 16.2% below its 200-day moving average. Technical signals show neutral RSI of 40 and bullish MACD crossover, explaining why RMTI maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 40) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$0.89
Potential Upside
5%
Whystock Fair Value$0.93
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Rockwell Medical, Inc., together with its subsidiaries, develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide. The company offers citrapure citric acid concentrate, dri-sate dry acid co...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$33.40M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.71
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-14.37%
Volume
Today's trading volume
149,233
Recent News
How The Rockwell Medical (RMTI) Story Is Shifting With Recalibrated Fair Value Targets
Rockwell Medical is back in focus after analysts shifted their fair value estimate for the shares from US$4.0 to US$3.0, resetting the key price reference investors often watch. Bulls frame this adjustment as a recalibration that keeps the long term story intact, while bears see it as a signal that assumptions around growth and execution now face a higher bar. As you read on, you will see how to interpret these moves and keep track of the evolving narrative around the stock. Stay updated as...
Should Value Investors Buy Rockwell Medical (RMTI) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Fast-paced Momentum Stock Rockwell Medical (RMTI) Is Still Trading at a Bargain
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Rockwell Medical (RMTI) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Rockwell Medical Inc (RMTI) Q4 2025 Earnings Call Highlights: Navigating Challenges with ...
Despite a challenging year, Rockwell Medical Inc (RMTI) achieved significant milestones in gross margin and cash flow, while expanding its customer base and strengthening key partnerships.
Rockwell Medical, Inc. Q4 2025 Earnings Call Summary
Moby summary of Rockwell Medical, Inc.'s Q4 2025 earnings call